Rhenman--Partners-Asset-Management-Ab

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
94
Total Value
869997756
Accession Number
0001213900-25-042939
Form Type
13F-HR
Manager Name
Rhenman--Partners-Asset-Management-Ab
Data Enrichment
98% identified
92 identified2 unidentified

Holdings

94 positions • $870.0M total value
Manager:
Search and click to pin securities to the top
BIOGEN INC.
Shares:49.5K
Value:$6.8M
% of Portfolio:0.8% ($6.8M/$870.0M)
ALIGN TECHNOLOGY INC
Shares:41.5K
Value:$6.6M
% of Portfolio:0.8% ($6.6M/$870.0M)
THERMO FISHER SCIENTIFIC INC.
Shares:12.6K
Value:$6.3M
% of Portfolio:0.7% ($6.3M/$870.0M)
HCA Healthcare, Inc.
Shares:16.8K
Value:$5.8M
% of Portfolio:0.7% ($5.8M/$870.0M)
Syndax Pharmaceuticals Inc
Shares:433.0K
Value:$5.3M
% of Portfolio:0.6% ($5.3M/$870.0M)
Anteris Technologies Global Corp.
Shares:1.3M
Value:$4.7M
% of Portfolio:0.5% ($4.7M/$870.0M)
03763A207
Shares:150.0K
Value:$4.7M
% of Portfolio:0.5% ($4.7M/$870.0M)
Verona Pharma plc
Shares:70.0K
Value:$4.4M
% of Portfolio:0.5% ($4.4M/$870.0M)
BECTON DICKINSON & CO
Shares:19.0K
Value:$4.4M
% of Portfolio:0.5% ($4.4M/$870.0M)
CYTOKINETICS INC
Shares:104.3K
Value:$4.2M
% of Portfolio:0.5% ($4.2M/$870.0M)
IQVIA HOLDINGS INC.
Shares:22.0K
Value:$3.9M
% of Portfolio:0.4% ($3.9M/$870.0M)
Janux Therapeutics, Inc.
Shares:141.6K
Value:$3.8M
% of Portfolio:0.4% ($3.8M/$870.0M)
Encompass Health Corp
Shares:37.4K
Value:$3.8M
% of Portfolio:0.4% ($3.8M/$870.0M)
Akero Therapeutics, Inc.
Shares:92.5K
Value:$3.7M
% of Portfolio:0.4% ($3.7M/$870.0M)
Nuvalent, Inc.
Shares:52.5K
Value:$3.7M
% of Portfolio:0.4% ($3.7M/$870.0M)
Mirum Pharmaceuticals, Inc.
Shares:73.8K
Value:$3.3M
% of Portfolio:0.4% ($3.3M/$870.0M)
BioNTech SE
Shares:35.8K
Value:$3.3M
% of Portfolio:0.4% ($3.3M/$870.0M)
Krystal Biotech, Inc.
Shares:17.8K
Value:$3.2M
% of Portfolio:0.4% ($3.2M/$870.0M)
Merus N.V.
Shares:74.5K
Value:$3.1M
% of Portfolio:0.4% ($3.1M/$870.0M)
Ultragenyx Pharmaceutical Inc.
Shares:82.0K
Value:$3.0M
% of Portfolio:0.3% ($3.0M/$870.0M)